Market Tracker

01/23 7:28am ET

Alimera Sciences Inc (NASDAQ:ALIM)

1.18
Delayed Data
As of Jan 20
 +0.01 / +0.85%
Today’s Change
1.01
Today|||52-Week Range
5.15
+9.26%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close1.17
Today’s open1.16
Day’s range1.15 - 1.18
Volume135,846
Average volume (3 months)276,318
Market cap$76.5M
Dividend yield--
Data as of 01/20/2017

Growth & Valuation

Earnings growth (last year)+24.18%
Earnings growth (this year)+42.52%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+166.39%
P/E ratioNM
Price/Sales4.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CEMIChembio Diagnostics ...-0.05-0.80%
IPCIIntellipharmaceutics...-0.06-2.31%
SCYXSCYNEXIS Inc-0.08-2.38%
PPHMPeregrine Pharmaceut...-0.00-0.79%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 8, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$22.4M
Annual profit (last year)-$30.6M
Net profit margin-136.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Charles Daniel Myers
President &
Chief Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts